EE9700079A - Enantiomeerselt puhaste tsükloalkaanindool- ja asaindool- ning pürimido(1,2-a)indoolkarboksüülhapete ja nende aktiveeritud derivaatide valmistamismeetod - Google Patents

Enantiomeerselt puhaste tsükloalkaanindool- ja asaindool- ning pürimido(1,2-a)indoolkarboksüülhapete ja nende aktiveeritud derivaatide valmistamismeetod

Info

Publication number
EE9700079A
EE9700079A EE9700079A EE9700079A EE9700079A EE 9700079 A EE9700079 A EE 9700079A EE 9700079 A EE9700079 A EE 9700079A EE 9700079 A EE9700079 A EE 9700079A EE 9700079 A EE9700079 A EE 9700079A
Authority
EE
Estonia
Prior art keywords
azaindole
pyrimido
cycloalkane
indole
preparation
Prior art date
Application number
EE9700079A
Other languages
English (en)
Estonian (et)
Inventor
Lenfers Jan-Bernd
Fey Peter
Naab Paul
Van Laak Kai
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of EE9700079A publication Critical patent/EE9700079A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/616—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/65—Halogen-containing esters of unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9700079A 1996-04-04 1997-04-03 Enantiomeerselt puhaste tsükloalkaanindool- ja asaindool- ning pürimido(1,2-a)indoolkarboksüülhapete ja nende aktiveeritud derivaatide valmistamismeetod EE9700079A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19613549A DE19613549A1 (de) 1996-04-04 1996-04-04 Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate

Publications (1)

Publication Number Publication Date
EE9700079A true EE9700079A (et) 1997-10-15

Family

ID=7790501

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700079A EE9700079A (et) 1996-04-04 1997-04-03 Enantiomeerselt puhaste tsükloalkaanindool- ja asaindool- ning pürimido(1,2-a)indoolkarboksüülhapete ja nende aktiveeritud derivaatide valmistamismeetod

Country Status (27)

Country Link
US (1) US5952498A (fr)
EP (1) EP0799829B1 (fr)
JP (2) JP4235268B2 (fr)
KR (1) KR970069988A (fr)
CN (2) CN1067394C (fr)
AR (2) AR006544A1 (fr)
AT (1) ATE246193T1 (fr)
AU (1) AU722592B2 (fr)
BR (1) BR9701672A (fr)
CA (1) CA2201435C (fr)
CZ (1) CZ102197A3 (fr)
DE (2) DE19613549A1 (fr)
DZ (1) DZ2202A1 (fr)
EE (1) EE9700079A (fr)
ES (1) ES2202506T3 (fr)
HR (1) HRP970178A2 (fr)
HU (1) HU218494B (fr)
ID (1) ID16794A (fr)
IL (1) IL120591A (fr)
MA (1) MA24130A1 (fr)
NO (2) NO308301B1 (fr)
NZ (1) NZ314498A (fr)
PL (1) PL319269A1 (fr)
SG (1) SG60050A1 (fr)
SK (1) SK42897A3 (fr)
TN (1) TNSN97060A1 (fr)
ZA (1) ZA972831B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
AU2001244635A1 (en) * 2000-03-30 2001-10-15 Yamanouchi Pharmaceutical Co..Ltd. Hydrazide derivatives
WO2005051382A1 (fr) * 2003-11-28 2005-06-09 Astellas Pharma Inc. Agent renforçant l'effet hypolipidemiant
PT1725234E (pt) 2004-03-05 2013-03-04 Univ Pennsylvania Métodos com efeitos secundários reduzidos para tratamento de patologias ou doenças associadas a hiperlipidemia e hipercolesterolemia
EP1737460A2 (fr) * 2004-04-09 2007-01-03 Janssen Pharmaceutica N.V. Mode d'administration intermittent pour le traitement de l'obésité avec des inhibiteurs de mtp
EP1951220A2 (fr) * 2005-10-18 2008-08-06 Aegerion Pharmaceuticals Compositions destinees a l'abbaissement du cholesterol serique et/ou des triglycerides
JP2009537505A (ja) * 2006-05-18 2009-10-29 バイエル・ヘルスケア・アクチェンゲゼルシャフト インプリタピドを含む薬学的組成物およびこの薬学的組成物の使用方法
JP2010513534A (ja) * 2006-12-21 2010-04-30 エージェリオン ファーマシューティカルズ， インコーポレイテッド Ｍｔｐインヒビターおよびコレステロール吸収インヒビターを含む組み合わせを用いて肥満症を処置する方法
WO2008124384A2 (fr) * 2007-04-03 2008-10-16 Aegerion Pharmaceuticals, Inc. Méthodes de traitement de l'hépatite c
SI2968284T1 (sl) 2013-03-14 2021-08-31 Osteoqc Inc. Alkil-amin harmin derivati za pospeševanje rasti kosti
JP7695496B2 (ja) 2018-08-14 2025-06-19 オシフィ セラピューティクス リミティド ライアビリティ カンパニー フルオロβ－カルボリン化合物
EP3836923B1 (fr) 2018-08-14 2024-10-16 OssiFi Therapeutics LLC Composés pyrrolo-dipyridine pour le traitement de perte osseuse
BR112023000808A2 (pt) 2020-07-29 2023-02-07 Amryt Pharmaceuticals Inc Lomitapida para uso em métodos para tratar hiperlipidemia e hipercolesterolemia em pacientes pediátricos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate
DE4208051A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Substituierte phenylessigsaeureamide
DE4302956A1 (de) * 1993-02-03 1994-08-04 Bayer Ag Substituierte Imidazo(4,5-b)pyridine und Benzimidazole
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate

Also Published As

Publication number Publication date
AR012048A2 (es) 2000-09-27
JPH1045759A (ja) 1998-02-17
CN1330065A (zh) 2002-01-09
DZ2202A1 (fr) 2002-12-03
IL120591A0 (en) 1997-08-14
US5952498A (en) 1999-09-14
CN1184109A (zh) 1998-06-10
HUP9700698A1 (hu) 1998-01-28
NZ314498A (en) 1999-09-29
JP4235268B2 (ja) 2009-03-11
DE19613549A1 (de) 1997-10-09
SG60050A1 (en) 1999-02-22
CN1067394C (zh) 2001-06-20
PL319269A1 (en) 1997-10-13
ES2202506T3 (es) 2004-04-01
NO971513L (no) 1997-10-06
BR9701672A (pt) 1998-11-03
IL120591A (en) 2000-11-21
AU722592B2 (en) 2000-08-10
TNSN97060A1 (fr) 2005-03-15
EP0799829B1 (fr) 2003-07-30
MX9702446A (es) 1997-10-31
CA2201435C (fr) 2006-12-12
NO20003784D0 (no) 2000-07-24
NO971513D0 (no) 1997-04-03
MA24130A1 (fr) 1997-10-01
KR970069988A (ko) 1997-11-07
EP0799829A1 (fr) 1997-10-08
NO308301B1 (no) 2000-08-28
ID16794A (id) 1997-11-13
CZ102197A3 (en) 1997-10-15
JP2008169218A (ja) 2008-07-24
ZA972831B (en) 1997-10-31
DE59710487D1 (de) 2003-09-04
HU9700698D0 (en) 1997-05-28
SK42897A3 (en) 1997-10-08
AR006544A1 (es) 1999-09-08
ATE246193T1 (de) 2003-08-15
HU218494B (hu) 2000-09-28
HRP970178A2 (en) 1998-04-30
AU1660297A (en) 1997-10-09
NO20003784L (no) 1997-10-06
CA2201435A1 (fr) 1997-10-04

Similar Documents

Publication Publication Date Title
FI951439L (fi) Mikro-organismit tryptofaanin tuottamista varten ja näiden valmistusmenetelmät
NO986051D0 (no) Antikonvulsive derivater for behandling av manisk-depressive mangler
FI973059L (fi) Menetelmä peryleeni-3,4-dikarboksyylihappoimidien valmistamiseksi ja puhdistamiseksi
FI945363L (fi) Uusia merkaptoasetyyliamidopyridatso (1,2)pyridatsiini-, pyratsolo(1,2)pyridatsiini-, pyridatso (1,2-a)(1,2)diatsepiini- ja pyratsolo(1,2-a)(1,2)diatsepiinijohdannaisia, jotka ovat käyttökelpoisia enkefalisaasin ja ACE:n estäjinä
FI20000085L (fi) Menetelmä terapeuttisesti aktiivisten 4-amino-substituoitujen 2-azabicyklo/3.3.1/nonaanijohdannaisten valmistamiseksi
BR9606743A (pt) Derivados indol úteis no tratamento de osteoporose
NO308301B1 (no) FremgangsmÕte for fremstilling av enantiomer-rene cykloalkanoindol- og azaindol- og pyrimido[1,2a]- indolkarboksylsyrer og deres aktiverte derivater, mellomprodukter samt anvendelse av disse
DE59509556D1 (de) Verfahren zur Herstellung von Perylenimiden, neue di-, tri- und tetrachromophore Perylenfarbstoffe und deren Verwendung
EE9700078A (et) Pürimido(1,2-a)indoolid, nende valmistamismeetod, kasutamine ravimite valmistamiseks,nimetatud indoole sisaldavad ravimid ning indoolide valmistamiseks kasutatavad karboksüülhapped ja nende valmistamismeetod
AU646771B2 (en) Intermediates useful in the preparation of substituted indolone derivatives
FI971527A7 (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
NO20001777L (no) Fremgangsmate for fremstilling av substituerte 4-fenyl-4-cyanocykloheksankarboksylsyrer
FI894506L (fi) Menetelmä valmistaa terapeuttisesti aktiivisia pyrido/1,2-a/indolijohdannaisia
NO952713D0 (no) Fremgangsmåte for fremstilling av substituerte indolonderivater
HUP9903988A3 (en) Process for the preparation of an inorganic salt of optically active phenylglycine derivative
NO942381L (no) Fremgangsmåte for fremstilling av indoler
NO932783D0 (no) Fremgangsmaate for fremstilling av imidazopyridiner
FI910448A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3b/indolijohdannaisten valmistamiseksi
FI963808L (fi) Menetelmä (1H-tetratsol-5-yyli)tetratsolo(1,5-a)kinoliinien ja naftyridiinien valmistamiseksi
EP0714659A3 (fr) Dérivés d'indole dans le traitement de l'emesis
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
NO991098L (no) FremgangsmÕte for fremstilling av 2-fenyl-3-naftylpropionsyrederivater
EE200100700A (et) Asendatud [1,4]diasepino[6,7,1-hi]indool-4-oonidevalmistamismeetod
AU2233097A (en) Process for the preparation of optically active indole compounds
FI951043A7 (fi) Menetelmä lääkeaineina käyttökelpoisten (1,2,3,10,14b-heksahydropyratsino(1,2-a)pyrrolo(2,1-c)(1,4)bentsatsepin-2-yyli)alkaanihappojen valmistamiseksi